Guangchuan Deng is an M.D. candidate in Oncology at The Second Affiliated Hospital of Chongqing Medical University. His primary research focuses on thoracic oncology, targeted therapy resistance, and intracranial progression in advanced lung cancer. Dr. Deng has extensive experience in clinical cohort studies and predictive modeling, with particular expertise in propensity score analysis, inverse probability weighting (IPTW), and MRI-based radiomics. He has actively contributed to several clinical and translational studies aimed at optimizing therapeutic strategies and improving survival outcomes for patients with brain metastases.
Disclosures:
- Employment: none
- Compensation: none
- Ownership: none
- Leadership: none